Large scale multiple sclerosis registry launches. CONTEXT: Announcement of The OM1 MS registry is a continually updating database of more than 20,000 patientsprospectively followed with deep clinical, laboratory and other data, such as longitudinal Continue Reading
CONTEXT: Presentation of a non-interventional study on breastfeeding mothers with Relapsing Multiple Sclerosis (MS) taking Copaxone at the 7th annual congress of the European Academy of Neurology (EAN). Around a Continue Reading
CONTEXT: Report from the American Academy of Neurology on Biogen’s main two MS compounds, with RWE showing value on detecting patient QoL and overall treatment preferences. READ TIME: 2 mins Quality Level Continue Reading
CONTEXT: European initiative to explore “In-Silico” research. Not so much “Real World” as “Brave New World” utilising computer models to test safety and efficacy of medical devices. Hopefully this isn’t Continue Reading
